Roth Capital Keeps Cerulean Pharma (CERU) at 'Buy' Amid Capital Raise, Key Collaboration with Novartis
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 4/23/2024
- Wall Street closes higher as investors digest earnings, megacap outlook
- Tesla touts acceleration of new models, but Q1 results fall short of estimates
- JPMorgan is worried about further S&P 500 sell-off potential
- Oil rises as dollar slips, focus shifts to economic data
- China acquired top-end Nvidia AI chips despite recent US ban- Reuters
- Fisker (FSR) Appoints Michael Healy as Chief Restructuring Officer
- Kroger (KR), Albertsons and C&S Wholesale Grocers Announce an Updated and Expanded Divestiture Plan
- Costar Group (CSGP) to Acquire Matterport (MTTR) for $5.50/sh Cash and Stock
- Jaguar Health (JAGX) Files $75M Mixed Shelf
- Apple (AAPL) PT Lowered to $210 at Morgan Stanley, 'We'd buy post-earnings weakness'
- After-hours movers: Tesla, Texas Instruments, Seagate, Visa and more
- Midday movers: PepsiCo, JetBlue fall; GM, Danaher and UPS rise
- After-hours movers: Cadence Design Systems, Cleveland-Cliffs, Riot Platforms, and more
- Midday movers: Tesla, Li Auto and CNH Industrial fall; Salesforce rises
- Midday movers: Netflix, Super Micro fall; Paramount Global gains
Leerink Affirms Cerulean Pharma (CERU) at 'Market Perform' Following Novartis Collab, Equity Raise
October 19, 2016 11:52 AM EDTLeerink affirms Cerulean Pharma (Nasdaq: CERU) with a Market Perform rating and $1.50 price target on the stock following news of a... More
Cerulean Pharma (CERU) Set to Open up 100% Following News of Strategic Collaboration with Novartis
October 19, 2016 8:24 AM EDTCerulean Pharma (NASDAQ: CERU) was set to open higher by 100% following news that it entered a strategic collaboration with Novartis.
... MoreCerulean Pharma (CERU), Novartis (NVS) Enter NDC Product Collaboration
October 19, 2016 8:12 AM EDTCerulean Pharma Inc. (Nasdaq: CERU) announced that the... More
Cerulean Pharma (CERU) Enters $20M Stock Purchase Agreement at $1.25/Share
October 19, 2016 8:11 AM EDTCerulean Pharma Inc. (Nasdaq: CERU) announced that it has entered into a $20 million common stock purchase agreement (Purchase Agreement) and a registration rights agreement (Registration Rights Agreement) with... More
